Trial Profile
Quality of Life Analysis of Prostate Cancer Patient's Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2010
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms AZTEC-EXT
- Sponsors AstraZeneca
- 09 Dec 2010 Actual initiation date changed from Jun 2007 to Jun 2008 as reported by ClinicalTrials.gov.
- 18 Nov 2010 Planned end date changed from 1 Jul 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 18 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.